Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
290 million people have viral hepatitis and don’t know it. Raise awareness with a virtual video relay.
A global study examined how outcomes improve when physicians engage their HIV-positive patients in joint decision-making.
An analysis of Danish families found that having a child with cancer didn’t affect family planning either.
The specific mode of transmission remains unknown.
A clinical trial compared injectable cabotegravir given every eight weeks versus daily Truvada for HIV prevention.
As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.
This finding, which is in keeping with initial studies out of China and Italy, is preliminary as the CDC continues to gather data.
The largest manufacturer makes one out of five condoms globally. It had to shut down production.
A study of 16 patients suggests the virus that causes COVID-19 can live inside the body for up to eight days after symptoms end.
Plus: Any restriction of civil and political rights must meet these five specific criteria.
Four key ways countries can prevent infections, save lives and minimize impact
Don’t be lured by phishing messages claiming to be from the World Health Organization, FedEx and others.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
As more cases arise, the CDC reminds the general public that immediate risk is still low.
Should you worry about your supply? Plus: Vice President Pence and AIDS expert Deborah Birx lead the U.S. coronavirus response.
Immediate risk of transmission to the American public is still low, according to experts.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.